TGen News & Press Releases : TGen discovers genetic mutation that causes the appearance of premature aging and severe loss of fat in children

"Fight with your feet" walk aims to "Stomp Out Cancer"

The Barbara L. Kahn Kids' Walk to Stomp Out Cancer is planned at noon Sunday, March 22, at Congregation Beth Israel.

This is the second year of the 1-mile walk, planned in part by Ethan, Gabrielle and Isabel Kahn, the grandchildren of Barbara Lynn Kahn, a northeast Valley resident who died of pancreatic cancer on Jan. 9, 2009.

The walk will benefit the Scottsdale Clinical Research Institute. The institute's work includes pancreatic cancer research by the Phoenix-based, non-profit Translational Genomics Research Institute (TGen) at TGen Clinical Research Services (TCRS) at the medical campus of Scottsdale Healthcare Shea.

TCRS, a partnership of TGen and Scottsdale Healthcare Corp., conducts clinical drug trials in an effort to find new treatments, and eventual cures, for pancreatic and other forms of cancer.

Last year, the walk raised nearly $7,000, and organizers hope to double that this year.

Participants are encouraged to bring a picnic lunch (dairy, vegetarian or fish) to the Congregation Beth Israel Ballroom and eat prior to the walk.

The "Fight With Your Feet!" fundraiser is designed for children, but all ages may participate. A lag car will pick up any walkers too tired to finish.

*

What: The Barbara L. Kahn Kids' Walk to Stop Out Cancer.

Where: Congregation Beth Israel, 10460 N. 56th St., southwest of Shea Boulevard and 56th Street.

When: Noon-1:30 p.m. Sunday, March 22, 2009.

What to bring: Participants are encouraged to wear comfortable shoes, sunscreen and hats, and to bring extra water, though water also will be provided along the walk.

Registration cost: $18 for individual; $36 for family. Children will receive t-shirts.

Details: www.cbiaz.org, or call Iris Cohn at 480-951-0323.

*

About TGen
The Translational Genomics Research Institute (TGen) is a non-profit organization dedicated to conducting groundbreaking research with life changing results. Research at TGen is focused on helping patients with diseases such as cancer, neurological disorders and diabetes. TGen is on the cutting edge of translational research where investigators are able to unravel the genetic components of common and complex diseases. Working with collaborators in the scientific and medical communities, TGen believes it can make a substantial contribution to the efficiency and effectiveness of the translational process.

Press Contact:
Steve Yozwiak
TGen Senior Science Writer
602-343-8704
[email protected]


Search



Media Contact



RSS Feed

Newsletter